GlassScriptPhysician profile
Eliyahu Kopstick
NPI 1225083546
$17,742.07
in general payments reported to CMS, 2019-2025
50 companies · $1,969 in 2025
The $1,969 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,495 · 2020: $2,391 · 2021: $2,107 · 2022: $2,709 · 2023: $2,580 · 2024: $2,491 · 2025: $1,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,040.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,400.98 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $3,297.94 | 2019-2025 | Farxiga, Breztri, Lokelma |
| Novo Nordisk INC | $1,289.57 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $816.17 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $753.08 | 2019-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $682.09 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $638.42 | 2022-2025 | Rexulti, Abilify Maintena |
| Kowa Pharmaceuticals America, INC. | $583.68 | 2019-2024 | Zoryve |
| Pfizer INC. | $560.55 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $526.07 | 2021-2025 | |
| Amgen INC. | $521.11 | 2019-2023 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $506.99 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $504.52 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Allergan, INC. | $452.39 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $392.96 | 2019-2025 | Trintellix |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eliyahu Kopstick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.